SEI Trust Company’s Vertex Pharmaceuticals VRTX Stock Holding History

SEI Trust Company’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$319K	Sell	2,843 -5,715	-67%	-$544K	﹤0.01%	1218
2014 Q2	$810K	Sell	8,558 -20,544	-71%	-$1.44M	0.01%	957
2014 Q1	$2.06M	Buy	29,102 +16	+0.1%	+$1.27K	0.02%	672
2013 Q4	$2.16M	Sell	29,086 -15,839	-35%	-$1.1M	0.02%	667
2013 Q3	$3.41M	Buy	44,925 +44,360	+7,851%	+$3.53M	0.04%	492
2013 Q2	$45K	Buy	+565	New	+$41.6K	﹤0.01%	1462

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

SEI Trust Company's VRTX Position: Q3 2014 in Review

SEI Trust Company reduced its Vertex Pharmaceuticals (VRTX) stake by 67% in Q3 2014, selling an estimated $544K and leaving 2,843 shares worth $319K. The position accounts for ﹤0.01% of the portfolio, ranked #1218.

SEI Trust Company first reported a position in VRTX in Q2 2013 and has held it in 6 quarters since. The position peaked at $3.41M in Q3 2013. 431 funds tracked by Wall St. Rank hold VRTX as of Q3 2014.

SEI Trust Company held 2,843 shares of Vertex Pharmaceuticals worth $319K as of Q3 2014.
SEI Trust Company sold 5,715 Vertex Pharmaceuticals shares in Q3 2014, an estimated $544K.
Vertex Pharmaceuticals made up ﹤0.01% of SEI Trust Company's portfolio in Q3 2014, its #1218 holding.
SEI Trust Company first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 6 quarters since.
SEI Trust Company's Vertex Pharmaceuticals position peaked at $3.41M in Q3 2013.
431 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2014.

Based on SEI Trust Company's 13F filing for Q3 2014, filed 28 Oct 2014.